13F HOLDINGS REPORT
Sofinnova Investments, Inc.
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001104659-23-118095
Total Value
$1.59B
Positions
69
Other Managers
0
Confidential Omitted
No
Holdings (69)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Karuna Therapeutics Inc | 48576A100 | 1,380,466 | $233.4M | 14.72% |
| 2 | Natera Inc | NTRA | 3,100,560 | $137.2M | 8.65% |
| 3 | AstraZeneca PLC | AZN | 1,362,836 | $92.3M | 5.82% |
| 4 | Merck & Co Inc | MRK | 728,404 | $75.0M | 4.73% |
| 5 | Ascendis Pharma A/S | ASND | 754,032 | $70.6M | 4.45% |
| 6 | RayzeBio Inc | 75525N107 | 2,419,528 | $53.7M | 3.39% |
| 7 | Dexcom Inc | DXCM | 550,197 | $51.3M | 3.24% |
| 8 | Aerovate Therapeutics Inc | 008064107 | 3,758,686 | $51.0M | 3.22% |
| 9 | Intuitive Surgical Inc | ISRG | 173,277 | $50.6M | 3.19% |
| 10 | Vera Therapeutics Inc | VERA | 3,467,156 | $47.5M | 3.00% |
| 11 | Elanco Animal Health Inc | ELAN | 3,610,024 | $40.6M | 2.56% |
| 12 | IShares TR | 464287655 | 225,000 | $39.8M | 2.51% |
| 13 | argenx SE | ARGX | 78,186 | $38.4M | 2.42% |
| 14 | Immatics NV | IMTX | 3,251,509 | $37.7M | 2.38% |
| 15 | Sanofi | SNYNF | 695,375 | $37.3M | 2.35% |
| 16 | Kenvue Inc | KVUE | 1,802,084 | $36.2M | 2.28% |
| 17 | IDEXX Laboratories Inc | 45168D104 | 77,881 | $34.1M | 2.15% |
| 18 | ImmunoGen Inc | 45253H101 | 2,045,202 | $32.5M | 2.05% |
| 19 | Cytokinetics Inc | CYTK | 1,060,164 | $31.2M | 1.97% |
| 20 | IDEAYA Biosciences Inc | IDYA | 1,037,187 | $28.0M | 1.77% |
| 21 | Zentalis Pharmaceuticals Inc | ZNTL | 1,211,641 | $24.3M | 1.53% |
| 22 | SPDR S&P 500 ETF Trust | SPY | 50,000 | $21.4M | 1.35% |
| 23 | Exelixis Inc | EXEL | 872,600 | $19.1M | 1.20% |
| 24 | Exelixis Inc | EXEL | 830,764 | $18.2M | 1.15% |
| 25 | Inozyme Pharma Inc | 45790W108 | 4,280,308 | $18.0M | 1.13% |
| 26 | Invesco QQQ TR | IVZ | 50,000 | $17.9M | 1.13% |
| 27 | MoonLake Immunotherapeutics | MLTX | 292,805 | $16.7M | 1.05% |
| 28 | Shockwave Med Inc | Shockwave | 81,373 | $16.2M | 1.02% |
| 29 | Agenus Inc | AGEN | 13,364,748 | $15.1M | 0.95% |
| 30 | Alkermes PLC | ALKS | 537,464 | $15.1M | 0.95% |
| 31 | Cytokinetics Inc | CYTK | 500,000 | $14.7M | 0.93% |
| 32 | Syndax Pharmaceuticals Inc | SNDX | 941,817 | $13.7M | 0.86% |
| 33 | Inhibrx Inc | INBX | 743,294 | $13.6M | 0.86% |
| 34 | Y-mAbs Therapeutics Inc | 984241109 | 2,194,278 | $12.0M | 0.75% |
| 35 | Celldex Therapeutics Inc | CLDX | 424,259 | $11.7M | 0.74% |
| 36 | Structure Therapeutics Inc | GPCR | 202,119 | $10.2M | 0.64% |
| 37 | CRISPR Therapeutics AG | CRSP | 200,000 | $9.1M | 0.57% |
| 38 | Replimune Group Inc | REPL | 503,844 | $8.6M | 0.54% |
| 39 | Marinus Pharmaceuticals Inc | 56854Q200 | 985,606 | $7.9M | 0.50% |
| 40 | Geron Corp | GERN | 3,702,546 | $7.8M | 0.50% |
| 41 | Syndax Pharmaceuticals Inc | SNDX | 450,000 | $6.5M | 0.41% |
| 42 | Sarepta Therapeutics Inc | SRPT | 51,100 | $6.2M | 0.39% |
| 43 | Dyne Therapeutics Inc | DYN | 685,133 | $6.1M | 0.39% |
| 44 | Axsome Therapeutics Inc | AXSM | 80,368 | $5.6M | 0.35% |
| 45 | Celldex Therapeutics Inc | CLDX | 200,000 | $5.5M | 0.35% |
| 46 | Immunovant Inc | IMVT | 139,885 | $5.4M | 0.34% |
| 47 | Replimune Group Inc | REPL | 313,100 | $5.4M | 0.34% |
| 48 | Syndax Pharmaceuticals Inc | SNDX | 300,000 | $4.4M | 0.27% |
| 49 | Syndax Pharmaceuticals Inc | SNDX | 300,000 | $4.4M | 0.27% |
| 50 | Replimune Group Inc | REPL | 250,000 | $4.3M | 0.27% |
| 51 | Nextcure Inc | NXTC | 2,671,856 | $3.4M | 0.22% |
| 52 | Nucana PLC | NCNA | 5,599,999 | $3.4M | 0.22% |
| 53 | Bolt Biotherapeutics Inc | BOLT | 2,754,437 | $2.9M | 0.18% |
| 54 | Marinus Pharmaceuticals Inc | 56854Q200 | 320,600 | $2.6M | 0.16% |
| 55 | Agenus Inc | AGEN | 1,600,000 | $1.8M | 0.11% |
| 56 | Nucana PLC | NCNA | 2,400,000 | $1.5M | 0.09% |
| 57 | Immatics NV | IMTX | 318,896 | $1.1M | 0.07% |
| 58 | Stryker Corporation | SYK | 3,279 | $896,052 | 0.06% |
| 59 | Exelixis Inc | EXEL | 40,000 | $874,000 | 0.06% |
| 60 | PDS Biotechnology Corp | PDSB | 142,635 | $720,307 | 0.05% |
| 61 | Savara Inc | SVRA | 157,908 | $596,892 | 0.04% |
| 62 | Galera Therapeutics Inc | GRTX | 3,083,712 | $539,958 | 0.03% |
| 63 | Ikena Oncology Inc | 45175G108 | 115,712 | $501,033 | 0.03% |
| 64 | Fusion Pharmaceuticals Inc | 36118A100 | 117,099 | $304,457 | 0.02% |
| 65 | Mirum Pharmaceuticals Inc | MIRM | 9,089 | $287,212 | 0.02% |
| 66 | CymaBay Therapeutics Inc | 23257D103 | 11,040 | $164,606 | 0.01% |
| 67 | Spruce Biosciences Inc | SPRB | 58,029 | $131,146 | 0.01% |
| 68 | Karuna Therapeutics Inc | 48576A100 | 683 | $115,488 | 0.01% |
| 69 | Synlogic Inc | SYBX | 38,331 | $107,710 | 0.01% |